Amid Pfizer's run as a global vaccine heavyweight—emphasized lately by its success with COVID-19 shot, Comirnaty—the company is losing a top scientist.
Kathrin Jansen, the leader of Pfizer's vaccine R&D group, has decided to retire, the company's Chief Scientific Officer Mikael Dolsten said in a LinkedIn post. The company plans to conduct a search for her replacement and will name a successor afterward, he said.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,